ArticleFrontiers in plant science2025
Control effects and mechanisms of metabolites from
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sunflower sclerotinia rot caused by Methods: Antagonism assays evaluated S769's efficacy in vitro, while detached leaf, pot, and field trials assessed disease suppression through soil mixing (S769-Ms) and root drenching (S769-i). Mechanistic analyses included enzyme activity assays, microbiome profiling, qPCR quantification of pathogen load, and root transcriptomics. Results: S769 exhibited 65.79% mycelial growth inhibition in vitro. Field trials demonstrated significant disease control (S769-Ms: 7.36%, S769-i: 5.92% vs. 14.69% control), with 15.85% increase in root fresh weight and 34.26% reduction in shriveled seeds. qPCR confirmed 4.85-fold pathogen reduction in leaves and 2.68-fold in roots. Transcriptomics revealed 6,622 upregulated genes, including MAPK signaling and phenylpropanoid biosynthesis pathways. Discussion: S769 demonstrates dual action through direct antifungal effects and host defense activation. The enrichment of beneficial rhizobacteria (Sphingomonas, Chitinophagaceae) without altering microbial diversity highlights its potential as a sustainable agricultural solution for sclerotinia rot management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.